Real-time PCR (qPCR) Market: Increasing prevalence of target
diseases and technological advancements such as the development of high
performance and superior qPCR are anticipated to boost the market at a healthy
CAGR of ~8.92% from 2021 to 2027
Market Highlights
According to MRFR analysis, the global Real-Time
PCR (Qpcr) Market is expected to register a CAGR of ~8.92 from 2021 to 2027
and hold a value of ~USD 8,398.55 million by 2027.
The global real-time PCR (qPCR) market is driven by
continued efforts by PCR manufacturers to develop novel kits and systems to be
used in molecular diagnostic testing. For example, in January 2019, Qiagen
N.V.(Germany) developed next-generation qPCR systems, which were launched in
April 2020. The new system isprojected to offer highly automated workflowand
quick turnaround time. This factor is likely to provide a significant
competitive advantage to the company, fueling the overall market growth of
Real-time PCR (qPCR).
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/10672
Key Players
Some of the key players in the global real-time PCR
(qPCR)marketareABL SA Group (Luxembourg), Agilent Technologies, Inc. (US),
Analytik Jena AG (Germany), BD (US), Bio-Rad Laboratories, Inc. (US), F.
Hoffmann-La Roche Ltd (Switzerland), Fluidigm Corporation (US), Lumex Instruments
(US), Primerdesign Ltd (UK), QIAGEN (Germany), Takara Bio Inc. (Japan), Thermo
Fisher Scientific (US), TOYOBO Inc. (Japan), and Vela Diagnostics (Singapore).
Severalglobal and local market players dominate the global
real-time PCR (qPCR) market, contributing to a substantial market share. The
prominent players are engaged in organic and inorganic strategies such
asagreements, new product development & launches, and approval from
government authorities, joint ventures, mergers & acquisitions, and partnerships
to sustaintheir market positions.For instance, in October 2017, AOAC
International (US), independent standards developing organization certified
Bio-Rad Laboratories (US) iQ-Check Real-time PCR (qPCR) Kit as the Official
Method of Analysis for Salmonella species identification in raw meat. Such
recognition to the company is anticipated to boost the market growth.
Regional Analysis
Based on region, North America is expectedto dominate the global real-time PCR
(qPCR) market in 2020 due to the rising adoption of novel and innovative
genomic analysis products and the availability of R&D grants.
The high prevalence of chronic & infectious diseases
coupled with increasing awareness among patients about early diagnosis of
diseases is propelling the market growth.
Europe is expected to hold the second-largest position in
the global real-time PCR (qPCR) market in 2021. Key factors attributing to the
market growth are increasing adoption of real-time PCR (qPCR) to diagnose and
estimate disease-causing microbes, with increasing product availability
forconsumers.
Furthermore, the growth in the rest of the world real-time
PCR (qPCR) market is attributed to the technological product advancements and
high penetration of advanced healthcare technologies in research organizations
focused on adopting real-time PCR (qPCR) as a testing methodin Saudi Arabia,
the UAE, and the other Middle Eastern and African countries. Developing
countries such as Brazil, Colombia, and Argentina, among others in Latin
America, are also key contributors to the growth of the market.
Access full report @ https://www.marketresearchfuture.com/reports/real-time-pcr-qpcr-market-10672
Segmentation
The global real-time PCR (qPCR) market has been segmented
into type, product, source, and application.
By product, the market has been segregated into reagents
& consumables, instruments, and software & services. The reagents &
consumables segment is expected to hold a considerable share of the market in
2021. Increasing adoption of reagents and consumables
Based on application,the real-time PCR (qPCR)market is
classified into clinical, research, forensics, and others. The clinical segment
held the largest market share in 2020. Some of the key factors attributing to
the market growth include the increasing adoption of Real-time PCR (qPCR) to
diagnose and estimate disease-causing microbes and other clinical ailments.
On the basis of the end user,the real-time PCR (qPCR) market
is segmented into hospitals & diagnostic centers, research laboratories
& academic institutes, pharmaceutical & biotechnology companies,
clinical research organizations, and forensic laboratories. The research
laboratories & academic institutes segment accounted for the major share in
2020 among the end user segment of the global real-time PCR (qPCR) market due
tothe increasing number of research laboratories and rising application of
Real-time PCR (qPCR) in sectors such as stem cell research and genetic disease
and oncology research.
Browse Complete
Report Details @ https://www.marketresearchfuture.com/reports/real-time-pcr-qpcr-market-10672
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The Wall